nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.015	0.5	CbGdCrCtD
Emtricitabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.015	0.5	CbGdCrCtD
Emtricitabine—Rash pustular—Niacin—atherosclerosis	0.0077	0.00793	CcSEcCtD
Emtricitabine—Proteinuria—Simvastatin—atherosclerosis	0.00761	0.00784	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00755	0.00779	CcSEcCtD
Emtricitabine—Protein urine present—Simvastatin—atherosclerosis	0.0075	0.00773	CcSEcCtD
Emtricitabine—Inflammation—Ezetimibe—atherosclerosis	0.00723	0.00745	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Niacin—atherosclerosis	0.00694	0.00715	CcSEcCtD
Emtricitabine—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00691	0.00712	CcSEcCtD
Emtricitabine—Inflammation—Simvastatin—atherosclerosis	0.00689	0.0071	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00683	0.00704	CcSEcCtD
Emtricitabine—Skin discolouration—Niacin—atherosclerosis	0.00679	0.00701	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Niacin—atherosclerosis	0.00675	0.00696	CcSEcCtD
Emtricitabine—Cough increased—Niacin—atherosclerosis	0.0067	0.00691	CcSEcCtD
Emtricitabine—Renal failure acute—Rosuvastatin—atherosclerosis	0.00663	0.00684	CcSEcCtD
Emtricitabine—Neuropathy—Pravastatin—atherosclerosis	0.00567	0.00585	CcSEcCtD
Emtricitabine—Rash maculo-papular—Niacin—atherosclerosis	0.00558	0.00575	CcSEcCtD
Emtricitabine—Urine output increased—Niacin—atherosclerosis	0.00555	0.00572	CcSEcCtD
Emtricitabine—Breast disorder—Rosuvastatin—atherosclerosis	0.00553	0.0057	CcSEcCtD
Emtricitabine—Muscular weakness—Rosuvastatin—atherosclerosis	0.0054	0.00557	CcSEcCtD
Emtricitabine—Pancreatitis—Rosuvastatin—atherosclerosis	0.00519	0.00535	CcSEcCtD
Emtricitabine—Polyuria—Niacin—atherosclerosis	0.00507	0.00523	CcSEcCtD
Emtricitabine—Renal failure acute—Pravastatin—atherosclerosis	0.00475	0.0049	CcSEcCtD
Emtricitabine—Depression—Rosuvastatin—atherosclerosis	0.0047	0.00485	CcSEcCtD
Emtricitabine—Dermatitis bullous—Niacin—atherosclerosis	0.00466	0.00481	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00462	0.00477	CcSEcCtD
Emtricitabine—Breast disorder—Ezetimibe—atherosclerosis	0.0046	0.00474	CcSEcCtD
Emtricitabine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00458	0.00473	CcSEcCtD
Emtricitabine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00455	0.00469	CcSEcCtD
Emtricitabine—Haematuria—Rosuvastatin—atherosclerosis	0.0045	0.00464	CcSEcCtD
Emtricitabine—Muscular weakness—Ezetimibe—atherosclerosis	0.00449	0.00463	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00449	0.00463	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00446	0.0046	CcSEcCtD
Emtricitabine—Sinusitis—Rosuvastatin—atherosclerosis	0.00443	0.00456	CcSEcCtD
Emtricitabine—Pancreatitis—Lovastatin—atherosclerosis	0.0044	0.00453	CcSEcCtD
Emtricitabine—Pancreatitis—Ezetimibe—atherosclerosis	0.00431	0.00444	CcSEcCtD
Emtricitabine—Muscular weakness—Simvastatin—atherosclerosis	0.00428	0.00441	CcSEcCtD
Emtricitabine—Rhinitis—Rosuvastatin—atherosclerosis	0.00425	0.00438	CcSEcCtD
Emtricitabine—Hepatitis—Rosuvastatin—atherosclerosis	0.00423	0.00437	CcSEcCtD
Emtricitabine—Pharyngitis—Rosuvastatin—atherosclerosis	0.0042	0.00433	CcSEcCtD
Emtricitabine—Pancreatitis—Simvastatin—atherosclerosis	0.00411	0.00424	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00409	0.00421	CcSEcCtD
Emtricitabine—Muscular weakness—Niacin—atherosclerosis	0.00393	0.00405	CcSEcCtD
Emtricitabine—Nasopharyngitis—Pravastatin—atherosclerosis	0.00392	0.00404	CcSEcCtD
Emtricitabine—Infestation—Ezetimibe—atherosclerosis	0.00392	0.00404	CcSEcCtD
Emtricitabine—Infestation NOS—Ezetimibe—atherosclerosis	0.00392	0.00404	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00392	0.00404	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.0039	0.00402	CcSEcCtD
Emtricitabine—Urinary tract infection—Lovastatin—atherosclerosis	0.00389	0.00401	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00387	0.00399	CcSEcCtD
Emtricitabine—Muscular weakness—Pravastatin—atherosclerosis	0.00387	0.00399	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00384	0.00396	CcSEcCtD
Emtricitabine—Sinusitis—Lovastatin—atherosclerosis	0.00375	0.00387	CcSEcCtD
Emtricitabine—Depression—Simvastatin—atherosclerosis	0.00373	0.00384	CcSEcCtD
Emtricitabine—Pancreatitis—Pravastatin—atherosclerosis	0.00372	0.00383	CcSEcCtD
Emtricitabine—Mental disorder—Rosuvastatin—atherosclerosis	0.00371	0.00382	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00371	0.00382	CcSEcCtD
Emtricitabine—Sinusitis—Ezetimibe—atherosclerosis	0.00368	0.00379	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00367	0.00378	CcSEcCtD
Emtricitabine—Hepatitis—Lovastatin—atherosclerosis	0.00359	0.0037	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00352	0.00363	CcSEcCtD
Emtricitabine—Hepatitis—Ezetimibe—atherosclerosis	0.00352	0.00363	CcSEcCtD
Emtricitabine—Sinusitis—Simvastatin—atherosclerosis	0.00351	0.00362	CcSEcCtD
Emtricitabine—Pharyngitis—Ezetimibe—atherosclerosis	0.00349	0.0036	CcSEcCtD
Emtricitabine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00346	0.00357	CcSEcCtD
Emtricitabine—Weight decreased—Pravastatin—atherosclerosis	0.00343	0.00354	CcSEcCtD
Emtricitabine—Depression—Pravastatin—atherosclerosis	0.00337	0.00348	CcSEcCtD
Emtricitabine—Angioedema—Rosuvastatin—atherosclerosis	0.00337	0.00347	CcSEcCtD
Emtricitabine—Hepatitis—Simvastatin—atherosclerosis	0.00336	0.00346	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00331	0.00342	CcSEcCtD
Emtricitabine—Urinary tract infection—Pravastatin—atherosclerosis	0.00329	0.00339	CcSEcCtD
Emtricitabine—Cough—Rosuvastatin—atherosclerosis	0.00322	0.00332	CcSEcCtD
Emtricitabine—Immune system disorder—Ezetimibe—atherosclerosis	0.00318	0.00328	CcSEcCtD
Emtricitabine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00317	0.00327	CcSEcCtD
Emtricitabine—Sinusitis—Pravastatin—atherosclerosis	0.00317	0.00327	CcSEcCtD
Emtricitabine—Arthralgia—Rosuvastatin—atherosclerosis	0.00314	0.00324	CcSEcCtD
Emtricitabine—Myalgia—Rosuvastatin—atherosclerosis	0.00314	0.00324	CcSEcCtD
Emtricitabine—Rhinitis—Niacin—atherosclerosis	0.00309	0.00319	CcSEcCtD
Emtricitabine—Mental disorder—Ezetimibe—atherosclerosis	0.00308	0.00318	CcSEcCtD
Emtricitabine—Hepatitis—Niacin—atherosclerosis	0.00308	0.00318	CcSEcCtD
Emtricitabine—Malnutrition—Ezetimibe—atherosclerosis	0.00306	0.00316	CcSEcCtD
Emtricitabine—Rhinitis—Pravastatin—atherosclerosis	0.00304	0.00314	CcSEcCtD
Emtricitabine—Hepatitis—Pravastatin—atherosclerosis	0.00303	0.00313	CcSEcCtD
Emtricitabine—Back pain—Lovastatin—atherosclerosis	0.00302	0.00312	CcSEcCtD
Emtricitabine—Pharyngitis—Pravastatin—atherosclerosis	0.00301	0.00311	CcSEcCtD
Emtricitabine—Infection—Rosuvastatin—atherosclerosis	0.00299	0.00308	CcSEcCtD
Emtricitabine—Back pain—Ezetimibe—atherosclerosis	0.00296	0.00306	CcSEcCtD
Emtricitabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00295	0.00304	CcSEcCtD
Emtricitabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00295	0.00304	CcSEcCtD
Emtricitabine—Mental disorder—Simvastatin—atherosclerosis	0.00294	0.00303	CcSEcCtD
Emtricitabine—Angioedema—Lovastatin—atherosclerosis	0.00285	0.00294	CcSEcCtD
Emtricitabine—Anaemia—Ezetimibe—atherosclerosis	0.00283	0.00292	CcSEcCtD
Emtricitabine—Angioedema—Ezetimibe—atherosclerosis	0.0028	0.00289	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00274	0.00283	CcSEcCtD
Emtricitabine—Insomnia—Rosuvastatin—atherosclerosis	0.00272	0.00281	CcSEcCtD
Emtricitabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.0027	0.00279	CcSEcCtD
Emtricitabine—Anaemia—Simvastatin—atherosclerosis	0.0027	0.00278	CcSEcCtD
Emtricitabine—Malnutrition—Niacin—atherosclerosis	0.00268	0.00277	CcSEcCtD
Emtricitabine—Cough—Ezetimibe—atherosclerosis	0.00267	0.00276	CcSEcCtD
Emtricitabine—Angioedema—Simvastatin—atherosclerosis	0.00267	0.00275	CcSEcCtD
Emtricitabine—Arthralgia—Lovastatin—atherosclerosis	0.00266	0.00274	CcSEcCtD
Emtricitabine—Myalgia—Lovastatin—atherosclerosis	0.00266	0.00274	CcSEcCtD
Emtricitabine—Anxiety—Lovastatin—atherosclerosis	0.00265	0.00273	CcSEcCtD
Emtricitabine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00265	0.00273	CcSEcCtD
Emtricitabine—Arthralgia—Ezetimibe—atherosclerosis	0.00261	0.00269	CcSEcCtD
Emtricitabine—Myalgia—Ezetimibe—atherosclerosis	0.00261	0.00269	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00259	0.00267	CcSEcCtD
Emtricitabine—Pain—Rosuvastatin—atherosclerosis	0.00257	0.00265	CcSEcCtD
Emtricitabine—Infection—Lovastatin—atherosclerosis	0.00253	0.00261	CcSEcCtD
Emtricitabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.0025	0.00257	CcSEcCtD
Emtricitabine—Arthralgia—Simvastatin—atherosclerosis	0.00249	0.00256	CcSEcCtD
Emtricitabine—Myalgia—Simvastatin—atherosclerosis	0.00249	0.00256	CcSEcCtD
Emtricitabine—Infection—Ezetimibe—atherosclerosis	0.00248	0.00256	CcSEcCtD
Emtricitabine—Anxiety—Simvastatin—atherosclerosis	0.00248	0.00256	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00246	0.00254	CcSEcCtD
Emtricitabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00245	0.00253	CcSEcCtD
Emtricitabine—Angioedema—Niacin—atherosclerosis	0.00245	0.00253	CcSEcCtD
Emtricitabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00245	0.00252	CcSEcCtD
Emtricitabine—Anaemia—Pravastatin—atherosclerosis	0.00244	0.00252	CcSEcCtD
Emtricitabine—Skin disorder—Ezetimibe—atherosclerosis	0.00243	0.0025	CcSEcCtD
Emtricitabine—Angioedema—Pravastatin—atherosclerosis	0.00241	0.00249	CcSEcCtD
Emtricitabine—Urticaria—Rosuvastatin—atherosclerosis	0.00239	0.00246	CcSEcCtD
Emtricitabine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00238	0.00245	CcSEcCtD
Emtricitabine—Infection—Simvastatin—atherosclerosis	0.00237	0.00244	CcSEcCtD
Emtricitabine—Cough—Niacin—atherosclerosis	0.00234	0.00241	CcSEcCtD
Emtricitabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00233	0.00241	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00232	0.00239	CcSEcCtD
Emtricitabine—Insomnia—Lovastatin—atherosclerosis	0.00231	0.00238	CcSEcCtD
Emtricitabine—Cough—Pravastatin—atherosclerosis	0.00231	0.00238	CcSEcCtD
Emtricitabine—Paraesthesia—Lovastatin—atherosclerosis	0.00229	0.00236	CcSEcCtD
Emtricitabine—Arthralgia—Niacin—atherosclerosis	0.00228	0.00235	CcSEcCtD
Emtricitabine—Myalgia—Niacin—atherosclerosis	0.00228	0.00235	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00228	0.00235	CcSEcCtD
Emtricitabine—Dyspnoea—Lovastatin—atherosclerosis	0.00227	0.00234	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00227	0.00234	CcSEcCtD
Emtricitabine—Insomnia—Ezetimibe—atherosclerosis	0.00226	0.00233	CcSEcCtD
Emtricitabine—Arthralgia—Pravastatin—atherosclerosis	0.00225	0.00232	CcSEcCtD
Emtricitabine—Myalgia—Pravastatin—atherosclerosis	0.00225	0.00232	CcSEcCtD
Emtricitabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00225	0.00232	CcSEcCtD
Emtricitabine—Dyspepsia—Lovastatin—atherosclerosis	0.00224	0.00231	CcSEcCtD
Emtricitabine—Anxiety—Pravastatin—atherosclerosis	0.00224	0.00231	CcSEcCtD
Emtricitabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00223	0.0023	CcSEcCtD
Emtricitabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00222	0.00229	CcSEcCtD
Emtricitabine—Dyspepsia—Ezetimibe—atherosclerosis	0.0022	0.00227	CcSEcCtD
Emtricitabine—Fatigue—Lovastatin—atherosclerosis	0.0022	0.00227	CcSEcCtD
Emtricitabine—Pain—Lovastatin—atherosclerosis	0.00218	0.00225	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00217	0.00224	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00216	0.00223	CcSEcCtD
Emtricitabine—Asthenia—Rosuvastatin—atherosclerosis	0.00216	0.00223	CcSEcCtD
Emtricitabine—Insomnia—Simvastatin—atherosclerosis	0.00216	0.00222	CcSEcCtD
Emtricitabine—Fatigue—Ezetimibe—atherosclerosis	0.00216	0.00222	CcSEcCtD
Emtricitabine—Infection—Pravastatin—atherosclerosis	0.00214	0.00221	CcSEcCtD
Emtricitabine—Paraesthesia—Simvastatin—atherosclerosis	0.00214	0.00221	CcSEcCtD
Emtricitabine—Pain—Ezetimibe—atherosclerosis	0.00214	0.0022	CcSEcCtD
Emtricitabine—Pruritus—Rosuvastatin—atherosclerosis	0.00213	0.00219	CcSEcCtD
Emtricitabine—Skin disorder—Niacin—atherosclerosis	0.00213	0.00219	CcSEcCtD
Emtricitabine—Dyspnoea—Simvastatin—atherosclerosis	0.00213	0.00219	CcSEcCtD
Emtricitabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00211	0.00218	CcSEcCtD
Emtricitabine—Dyspepsia—Simvastatin—atherosclerosis	0.0021	0.00216	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00208	0.00215	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00206	0.00212	CcSEcCtD
Emtricitabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00206	0.00212	CcSEcCtD
Emtricitabine—Fatigue—Simvastatin—atherosclerosis	0.00206	0.00212	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00204	0.00211	CcSEcCtD
Emtricitabine—Pain—Simvastatin—atherosclerosis	0.00204	0.0021	CcSEcCtD
Emtricitabine—Urticaria—Lovastatin—atherosclerosis	0.00203	0.00209	CcSEcCtD
Emtricitabine—Body temperature increased—Lovastatin—atherosclerosis	0.00202	0.00208	CcSEcCtD
Emtricitabine—Abdominal pain—Lovastatin—atherosclerosis	0.00202	0.00208	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00199	0.00206	CcSEcCtD
Emtricitabine—Dizziness—Rosuvastatin—atherosclerosis	0.00199	0.00205	CcSEcCtD
Emtricitabine—Urticaria—Ezetimibe—atherosclerosis	0.00199	0.00205	CcSEcCtD
Emtricitabine—Insomnia—Niacin—atherosclerosis	0.00198	0.00204	CcSEcCtD
Emtricitabine—Body temperature increased—Ezetimibe—atherosclerosis	0.00198	0.00204	CcSEcCtD
Emtricitabine—Abdominal pain—Ezetimibe—atherosclerosis	0.00198	0.00204	CcSEcCtD
Emtricitabine—Paraesthesia—Niacin—atherosclerosis	0.00197	0.00203	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00196	0.00203	CcSEcCtD
Emtricitabine—Dyspnoea—Niacin—atherosclerosis	0.00195	0.00201	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00195	0.00201	CcSEcCtD
Emtricitabine—Insomnia—Pravastatin—atherosclerosis	0.00195	0.00201	CcSEcCtD
Emtricitabine—Paraesthesia—Pravastatin—atherosclerosis	0.00194	0.002	CcSEcCtD
Emtricitabine—Dyspepsia—Niacin—atherosclerosis	0.00193	0.00199	CcSEcCtD
Emtricitabine—Dyspnoea—Pravastatin—atherosclerosis	0.00192	0.00198	CcSEcCtD
Emtricitabine—Dyspepsia—Pravastatin—atherosclerosis	0.0019	0.00196	CcSEcCtD
Emtricitabine—Rash—Rosuvastatin—atherosclerosis	0.0019	0.00196	CcSEcCtD
Emtricitabine—Dermatitis—Rosuvastatin—atherosclerosis	0.0019	0.00195	CcSEcCtD
Emtricitabine—Urticaria—Simvastatin—atherosclerosis	0.00189	0.00195	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00189	0.00195	CcSEcCtD
Emtricitabine—Abdominal pain—Simvastatin—atherosclerosis	0.00189	0.00194	CcSEcCtD
Emtricitabine—Body temperature increased—Simvastatin—atherosclerosis	0.00189	0.00194	CcSEcCtD
Emtricitabine—Headache—Rosuvastatin—atherosclerosis	0.00188	0.00194	CcSEcCtD
Emtricitabine—Hypersensitivity—Lovastatin—atherosclerosis	0.00188	0.00194	CcSEcCtD
Emtricitabine—Pain—Niacin—atherosclerosis	0.00187	0.00193	CcSEcCtD
Emtricitabine—Fatigue—Pravastatin—atherosclerosis	0.00186	0.00192	CcSEcCtD
Emtricitabine—Pain—Pravastatin—atherosclerosis	0.00184	0.0019	CcSEcCtD
Emtricitabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00184	0.0019	CcSEcCtD
Emtricitabine—Asthenia—Lovastatin—atherosclerosis	0.00183	0.00189	CcSEcCtD
Emtricitabine—Pruritus—Lovastatin—atherosclerosis	0.0018	0.00186	CcSEcCtD
Emtricitabine—Asthenia—Ezetimibe—atherosclerosis	0.00179	0.00185	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Niacin—atherosclerosis	0.00179	0.00185	CcSEcCtD
Emtricitabine—Nausea—Rosuvastatin—atherosclerosis	0.00179	0.00184	CcSEcCtD
Emtricitabine—Pruritus—Ezetimibe—atherosclerosis	0.00177	0.00182	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00176	0.00182	CcSEcCtD
Emtricitabine—Hypersensitivity—Simvastatin—atherosclerosis	0.00176	0.00181	CcSEcCtD
Emtricitabine—Diarrhoea—Lovastatin—atherosclerosis	0.00174	0.0018	CcSEcCtD
Emtricitabine—Urticaria—Niacin—atherosclerosis	0.00174	0.00179	CcSEcCtD
Emtricitabine—Abdominal pain—Niacin—atherosclerosis	0.00173	0.00178	CcSEcCtD
Emtricitabine—Body temperature increased—Niacin—atherosclerosis	0.00173	0.00178	CcSEcCtD
Emtricitabine—Urticaria—Pravastatin—atherosclerosis	0.00171	0.00177	CcSEcCtD
Emtricitabine—Asthenia—Simvastatin—atherosclerosis	0.00171	0.00176	CcSEcCtD
Emtricitabine—Diarrhoea—Ezetimibe—atherosclerosis	0.00171	0.00176	CcSEcCtD
Emtricitabine—Body temperature increased—Pravastatin—atherosclerosis	0.0017	0.00176	CcSEcCtD
Emtricitabine—Abdominal pain—Pravastatin—atherosclerosis	0.0017	0.00176	CcSEcCtD
Emtricitabine—Pruritus—Simvastatin—atherosclerosis	0.00169	0.00174	CcSEcCtD
Emtricitabine—Dizziness—Lovastatin—atherosclerosis	0.00169	0.00174	CcSEcCtD
Emtricitabine—Dizziness—Ezetimibe—atherosclerosis	0.00165	0.0017	CcSEcCtD
Emtricitabine—Diarrhoea—Simvastatin—atherosclerosis	0.00163	0.00168	CcSEcCtD
Emtricitabine—Vomiting—Lovastatin—atherosclerosis	0.00162	0.00167	CcSEcCtD
Emtricitabine—Hypersensitivity—Niacin—atherosclerosis	0.00161	0.00166	CcSEcCtD
Emtricitabine—Rash—Lovastatin—atherosclerosis	0.00161	0.00166	CcSEcCtD
Emtricitabine—Dermatitis—Lovastatin—atherosclerosis	0.00161	0.00166	CcSEcCtD
Emtricitabine—Headache—Lovastatin—atherosclerosis	0.0016	0.00165	CcSEcCtD
Emtricitabine—Vomiting—Ezetimibe—atherosclerosis	0.00159	0.00164	CcSEcCtD
Emtricitabine—Hypersensitivity—Pravastatin—atherosclerosis	0.00159	0.00164	CcSEcCtD
Emtricitabine—Dizziness—Simvastatin—atherosclerosis	0.00158	0.00163	CcSEcCtD
Emtricitabine—Rash—Ezetimibe—atherosclerosis	0.00158	0.00163	CcSEcCtD
Emtricitabine—Dermatitis—Ezetimibe—atherosclerosis	0.00158	0.00162	CcSEcCtD
Emtricitabine—Asthenia—Niacin—atherosclerosis	0.00157	0.00162	CcSEcCtD
Emtricitabine—Headache—Ezetimibe—atherosclerosis	0.00157	0.00162	CcSEcCtD
Emtricitabine—Pruritus—Niacin—atherosclerosis	0.00155	0.0016	CcSEcCtD
Emtricitabine—Asthenia—Pravastatin—atherosclerosis	0.00155	0.00159	CcSEcCtD
Emtricitabine—Pruritus—Pravastatin—atherosclerosis	0.00153	0.00157	CcSEcCtD
Emtricitabine—Vomiting—Simvastatin—atherosclerosis	0.00152	0.00156	CcSEcCtD
Emtricitabine—Nausea—Lovastatin—atherosclerosis	0.00151	0.00156	CcSEcCtD
Emtricitabine—Rash—Simvastatin—atherosclerosis	0.0015	0.00155	CcSEcCtD
Emtricitabine—Dermatitis—Simvastatin—atherosclerosis	0.0015	0.00155	CcSEcCtD
Emtricitabine—Diarrhoea—Niacin—atherosclerosis	0.0015	0.00154	CcSEcCtD
Emtricitabine—Headache—Simvastatin—atherosclerosis	0.00149	0.00154	CcSEcCtD
Emtricitabine—Nausea—Ezetimibe—atherosclerosis	0.00149	0.00153	CcSEcCtD
Emtricitabine—Diarrhoea—Pravastatin—atherosclerosis	0.00148	0.00152	CcSEcCtD
Emtricitabine—Dizziness—Niacin—atherosclerosis	0.00145	0.00149	CcSEcCtD
Emtricitabine—Dizziness—Pravastatin—atherosclerosis	0.00143	0.00147	CcSEcCtD
Emtricitabine—Nausea—Simvastatin—atherosclerosis	0.00142	0.00146	CcSEcCtD
Emtricitabine—Vomiting—Niacin—atherosclerosis	0.00139	0.00144	CcSEcCtD
Emtricitabine—Rash—Niacin—atherosclerosis	0.00138	0.00142	CcSEcCtD
Emtricitabine—Dermatitis—Niacin—atherosclerosis	0.00138	0.00142	CcSEcCtD
Emtricitabine—Headache—Niacin—atherosclerosis	0.00137	0.00141	CcSEcCtD
Emtricitabine—Vomiting—Pravastatin—atherosclerosis	0.00137	0.00141	CcSEcCtD
Emtricitabine—Rash—Pravastatin—atherosclerosis	0.00136	0.0014	CcSEcCtD
Emtricitabine—Dermatitis—Pravastatin—atherosclerosis	0.00136	0.0014	CcSEcCtD
Emtricitabine—Headache—Pravastatin—atherosclerosis	0.00135	0.00139	CcSEcCtD
Emtricitabine—Nausea—Niacin—atherosclerosis	0.0013	0.00134	CcSEcCtD
Emtricitabine—Nausea—Pravastatin—atherosclerosis	0.00128	0.00132	CcSEcCtD
